In conclusion, our results demonstrate that the overexpression of the VEGFA/CTNNB1/MMP7/CD44 oncogenic signatures is associated with progression, immune infiltration, drug resistance, metastasis, and poor clinical outcomes in CRC. Here, CD44 is linked to colorectal carcinoma.